WallStSmart

Arch Capital Group Ltd. (ACGL)vsMetLife Inc (MET)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MetLife Inc generates 313% more annual revenue ($79.40B vs $19.23B). ACGL leads profitability with a 24.4% profit margin vs 4.6%. MET appears more attractively valued with a PEG of 0.51. ACGL earns a higher WallStSmart Score of 67/100 (B-).

ACGL

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 8.0Value: 7.0Quality: 6.0
Piotroski: 6/9Altman Z: 1.48

MET

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 5.0Value: 6.3Quality: 6.0
Piotroski: 4/9Altman Z: 0.08

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACGL6 strengths · Avg: 9.0/10
P/E RatioValuation
7.7x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Profit MarginProfitability
24.4%9/10

Keeps 24 of every $100 in revenue as profit

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

Operating MarginProfitability
26.6%8/10

Strong operational efficiency at 26.6%

Free Cash FlowQuality
$1.31B8/10

Generating 1.3B in free cash flow

MET4 strengths · Avg: 8.3/10
Market CapQuality
$61.73B9/10

Large-cap with strong market position

PEG RatioValuation
0.518/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$2.23B8/10

Generating 2.2B in free cash flow

Areas to Watch

ACGL3 concerns · Avg: 2.0/10
Revenue GrowthGrowth
-10.5%2/10

Revenue declined 10.5%

EPS GrowthGrowth
-7.1%2/10

Earnings declined 7.1%

Altman Z-ScoreHealth
1.482/10

Distress zone — elevated risk

MET2 concerns · Avg: 2.5/10
Profit MarginProfitability
4.6%3/10

4.6% margin — thin

Altman Z-ScoreHealth
0.082/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACGL

The strongest argument for ACGL centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 24.4% and operating margin at 26.6%. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bull Case : MET

The strongest argument for MET centers on Market Cap, PEG Ratio, Price/Book. Revenue growth of 10.5% demonstrates continued momentum. PEG of 0.51 suggests the stock is reasonably priced for its growth.

Bear Case : ACGL

The primary concerns for ACGL are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : MET

The primary concerns for MET are Profit Margin, Altman Z-Score. Thin 4.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

ACGL profiles as a declining stock while MET is a value play — different risk/reward profiles.

MET carries more volatility with a beta of 0.76 — expect wider price swings.

MET is growing revenue faster at 10.5% — sustainability is the question.

MET generates stronger free cash flow (2.2B), providing more financial flexibility.

Bottom Line

ACGL scores higher overall (67/100 vs 63/100), backed by strong 24.4% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arch Capital Group Ltd.

FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA

Arch Capital Group Ltd., offers insurance, reinsurance and mortgage products worldwide. The company is headquartered in Pembroke, Bermuda.

MetLife Inc

FINANCIAL SERVICES · INSURANCE - LIFE · USA

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with 90 million customers in over 60 countries.

Want to dig deeper into these stocks?